What are the recommended insulin therapy guidelines for hospitalized patients, including initiation thresholds, basal‑bolus dosing for non‑critical patients, continuous intravenous regular insulin for critically ill or hemodynamically unstable patients, and dose adjustments for renal impairment, high‑dose steroid therapy, and hypoglycemia risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

When is intravenous regular insulin indicated for severe hyperglycemia?
How should I initiate and taper an intravenous insulin infusion in a hyperglycemic patient, and what dosing regimen should be used?
What should a primary care physician do at the initial diagnosis of diabetes, including which baseline investigations and monitoring should be ordered?
In an elderly patient taking glipizide 10 mg daily and acarbose 100 mg daily who has a low A1c and frequent hypoglycemia, how should the diabetes regimen be adjusted?
How is the glucose infusion rate (GIR) calculated for treating hypoglycemia?
What is the recommended management of severe preeclampsia (blood pressure ≥160/110 mm Hg) in pregnancy, including admission, monitoring, antihypertensive therapy, magnesium sulfate seizure prophylaxis, laboratory evaluation, corticosteroid use, and timing of delivery?
What is the recommended dosing, administration schedule, monitoring, and contraindications for romosumab (Evenity) therapy?
What is the recommended evaluation and treatment for a patient with chronic progressive swelling, numbness, and shooting pain in the second and third toes spreading to the hallux, occurring years after a toe injury with no fracture?
Is it safe to give ursodeoxycholic acid (UDCA) during pregnancy?
What is the recommended evaluation and management for a patient with hepatomegaly and diffuse fatty liver consistent with metabolic dysfunction‑associated steatotic liver disease (MASLD)?
How is pericardial effusion classified into mild, moderate, and severe based on echocardiographic measurements, and what are the recommended management approaches for each severity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.